The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer

Human Pathology

Volumn 41, Issue 12, 2010, Pages 1735-1741

  Eijsink, Jasper J H ^a   Noordhuis, Maartje G ^a   Ten Hoor, Klaske A ^a   Kok, Mirjam ^a   Hollema, Harry ^a   De Bock, Geertruida H ^a   Nijman, Hans W ^a   Schuuring, Ed ^a   Wisman, G Bea A ^a   Van Der Zee, Ate G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cervical cancer; EGFR pathway; Metastasis; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN; PROTEIN KINASE B;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PELVIS; PHOSPHORYLATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78449305864     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.04.017     Document Type: Article

References (33)

1. Fuller A.F. Jr., Elliott N., Kosloff C., Hoskins W.J., and Lewis J.L. Jr Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix Gynecol Oncol 33 1989 34 39
2. Gallion H.H., van Nagell J.R. Jr., and Donaldson E.S. Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer Cancer 56 1985 262 265
3. Matsuyama T., Inoue I., and Tsukamoto N. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis Cancer 54 1984 3072 3077
4. Sevin B.U., Nadji M., and Lampe B. Prognostic factors of early stage cervical cancer treated by radical hysterectomy Cancer 76 10 Suppl 1995 1978 1986
5. Creasman W.T., and Kohler M.F. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol 92 2004 525 529
6. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer Int J Clin Oncol 12 2007 165 175
7. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2001 127 137
8. Blanco-Aparicio C., Renner O., Leal J.F., and Carnero A. PTEN, more than the AKT pathway Carcinogenesis 28 2007 1379 1386
9. Sansal I., and Sellers W.R. The biology and clinical relevance of the PTEN tumor suppressor pathway J Clin Oncol 22 2004 2954 2963
10. Hale R.J., Buckley C.H., Gullick W.J., Fox H., Williams J., and Wilcox F.L. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma J Clin Pathol 46 1993 149 153
11. Kersemaekers A.M., Fleuren G.J., and Kenter G.G. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis Clin Cancer Res 5 1999 577 586
12. Kristensen G.B., Holm R., Abeler V.M., and Trope C.G. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study Cancer 78 1996 433 440
13. Lee J.S., Choi Y.D., and Lee J.H. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma J Surg Oncol 93 2006 233 240
14. Nijhuis E.R., Nijman H.W., and Oien K.A. Loss of MSH2 protein expression is a risk factor in early stage cervical cancer J Clin Pathol 60 2007 824 830
15. de Graeff P., Crijns A.P., and Ten Hoor K.A. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer Br J Cancer 99 2008 341 349
16. Cheung T.H., Lo K.W., and Yim S.F. Epigenetic and genetic alternation of PTEN in cervical neoplasm Gynecol Oncol 93 2004 621 627
17. Wiley H.S. Trafficking of the ErbB receptors and its influence on signaling Exp Cell Res 284 2003 78 88
18. Fons G., van d V., Burger M., and ten K.F. Validation of tissue microarray technology in vulvar cancer Int J Gynecol Pathol 28 2009 76 82
19. Dankort D., Curley D.P., and Cartlidge R.A. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma Nat Genet 41 2009 544 552
20. Sawai H., Yasuda A., and Ochi N. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival BMC Gastroenterol 2008 856
21. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate J Biol Chem 273 1998 13375 13378
22. Bertelsen B.I., Steine S.J., Sandvei R., Molven A., and Laerum O.D. Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation Int J Cancer 118 2006 1877 1883
23. Faried L.S., Faried A., and Kanuma T. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy Oncol Rep 16 2006 57 63
24. Kim T.J., Lee J.W., and Song S.Y. Increased expression of pAKT is associated with radiation resistance in cervical cancer Br J Cancer 94 2006 1678 1682
25. Parsons D.W., Wang T.L., and Samuels Y. Colorectal cancer: mutations in a signalling pathway Nature 436 2005 792
26. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501
27. Talotta F., Cimmino A., and Matarazzo M.R. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation Oncogene 2008
28. Yang H., Kong W., and He L. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
29. Su T.H., Chang J.G., and Perng L.I. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer Gynecol Oncol 76 2000 193 199
30. Lee J.W., Choi C.H., and Choi J.J. Altered MicroRNA expression in cervical carcinomas Clin Cancer Res 14 2008 2535 2542
31. Lui W.O., Pourmand N., Patterson B.K., and Fire A. Patterns of known and novel small RNAs in human cervical cancer Cancer Res 67 2007 6031 6043
32. Neshat M.S., Mellinghoff I.K., and Tran C. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proc Natl Acad Sci U S A 98 2001 10314 10319
33. Podsypanina K., Lee R.T., and Politis C. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice Proc Natl Acad Sci U S A 98 2001 10320 10325